: FLXN

Flexion Therapeutics Inc (NASDAQ: FLXN)

Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of anti-inflammatory and analgesic therapies for the treatment of patients with musculoskeletal conditions. It lead product candidate includes Zilretta, an intra-articular injection for the management of osteoarthritis (OA) pain of the knee. Take a look at the 1-year chart of Flexion (NASDAQ: FLXN)… Continue Reading »